E.g., 12/14/2019
E.g., 12/14/2019
Title Category Credit Event Date Price
AUA2018 San Francisco Virtual Meeting (2018) $699.00 NEW for 2018: AUA2018 Virtual Meeting - Members Save $100!Access the latest science from the 2018 AUA Annual Meeting with the AUA2018 VIRTUAL MEETING.The Virtual Meeting provides online access to hundreds of scientific presentations from AUA2018, including:
AUA2019 Chicago - Virtual Course Pass (2019) $399.00 The AUA2019 Course Pass Bundle included the Live Course Pass PLUS online access to all 80+ Instructional Courses presented at AUA2019. NOTE: This product is only available to AUAU2019 attendees. If you were not able to attend AUA2019 and would like access to this important educational content, please see the AUA2019 Virtual Meeting.  
AUA2019 Chicago - Virtual Meeting (2019) $699.00 Didn't make it to Chicago for the 2019 AUA Annual Meeting? Access the latest science from AUA2019 with the AUA2019 Virtual Meeting! For more than a century, the AUA has stood at the forefront in developing innovative, evidence-based quality education for urologists and urologic health care professionals worldwide. Through the Annual Meeting—and other year-round educational offerings—the AUA sets the highest standards for urologic education worldwide.
Basic Urologic Ultrasound (2019)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$125.00 The use of ultrasound is fundamental to the practice of urology. Urologists use ultrasound daily in the office and in the surgical setting to diagnose urologic disease and to guide treatment. In order for urologists to achieve the best possible outcomes from this technology they must have a thorough understanding of the physical principles of ultrasound, the principles of image generation and the common artifacts associated with ultrasound. By viewing this online video, urologists will become acquainted with the effects of technique and machine adjustments on image quality.
Best of AUA- BPH: Minimally Invasive/ Surgical Options for Treating mLUTS and BPH (2017) $0.00 This 90 minute FREE non-cme webinar focuses on the topic of BPH.  AUA’s Secretary, Dr. Manoj Monga, is joined by expert faculties Drs. Alexis E. Te, M.D. and Dicken Shiu-Chung Ko for an exciting program featuring didactic lectures on Minimally Invasive/Surgical Options for treating mLUTS and BPH, Medical Therapy with both Mono and Combination Therapy with agents such as alpha blockers, antimuscarinics, 5-alpha reductase inhibitors, PDE-5 inhibitors, as well as step-by-step reviews of surgical videos including: 
Best of AUA: OAB: International Webinar (2017) $0.00 AUA is pleased to bring this 90 minute FREE non-cme webinar educational series to the global urologic community.  Dr. Robert J. Evans (Wake Forest) will be joined by expert faculties Drs. Howard B. Goldman (Cleveland Clinic) and Anurag Das (Beth Israel) for an exciting program featuring didactic lectures on the Urodynamic Evaluation and Advances in the Management of Adult Neurogenic Lower Urinary Tract Dysfunction as well as Highlights and Take Home Messages from AUA 2016 for treating Female Urology, Incontinence, and Urodynamics. 
Castration-Resistant Prostate Cancer (CRPC) Guideline Amendment Webcast (2018)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC), the AUA and Urology Care Foundation has produced a series of online activities and educational resources for healthcare professionals, patients and caregivers. One of those such activities is this complimentary AUA Castration-Resistant Prostate Cancer Guideline Amendment webcast.
Chemo-ablation of Upper-Tract Urothelial Carcinoma Podcast (2019)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Chemotherapy and Immunotherapy Options for Genitourinary Malignancies: A Primer for Urologists and Advanced Practice Providers Webcast 023IC (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, prostate, and testis cancers. Indications, outcomes, and toxicities will be discussed as well as clinical trial concepts. Survivorship issues will also be a focus of the session, which will include short, direct didactic lectures as well as a question and answer period. Standard of care chemotherapy regimens (eg MVAC for urothelial carcinoma) as well as newer immunotherapy options (eg checkpoint inhibition for renal cell carcinoma) will be included.
Clinical Cases in Urology: Diagnosis and Treatment of Early Stage Testicular Cancer (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Cases in Urology guideline-based case scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA Guideline, Diagnosis and Treatment of Early Stage Testicular Cancer. 
Clinical Cases in Urology: Incontinence after Prostate Treatment (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The The Clinical Cases in Urology guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA/SUFU Guideline, Incontinence after Prostate Treatment.
Clinical Cases in Urology: Recurrent Uncomplicated Urinary Tract Infections in Women (2019)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
$0.00 Member only benefit! AUA Guidelines provide a comprehensive and rigorous summary of evidence relating to a variety of disease conditions, providing an indispensable resource for urologic education. The Clinical Cases in Urology guideline-based Case Scenarios were designed to help maximize the impact of the guidelines. This case will focus on the AUA/CUA/SUFU Guideline, Recurrent Uncomplicated Urinary Tract Infections in Women.
Clinical Investigations in the Treatment of Urothelial Carcinoma Podcast (2019)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Comorbidities in Advanced Prostate Cancer Podcast (2019)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 To encourage consistent, high quality, evidence-based treatment of patients, the AUA is launching a series of podcast episodes designed to improve the ability of the urologist to care for patients with prostate, bladder and kidney cancers. These activities are designed to increase the clinician’s competence in the application of new and emerging treatment options, including their mechanism of action and associated side effects.
Complex Patient Cases in Bladder Cancer Webcast (2017)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The AUA developed the Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer initiative to include multiple educational interventions to improve the urologist, medical oncologist, and other healthcare provider's ability to care for patients with bladder cancer. These activities are designed to increase the clinician's competence in the application of new and emerging treatment options, including the sequencing and associated side effects of those options.

Pages